SET facilitates immune escape of microsatellite stability colorectal cancer by inhibiting c‐Myc degradation
Cancer Science · 2025
DOI: 10.1111/cas.16368 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Liping Gao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Microsatellite Instability, Proto-Oncogene Proteins c-myc, F-Box-WD Repeat-Containing Protein 7. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, The Young Top-notch Talent Cultivation Program of Hubei Province, Zhongnan Hospital of Wuhan University.
Abstract (Originalsprache)
Microsatellite stability (MSS) colorectal cancer (CRC) exhibits a low mutation load and poor immunogenicity, contributing to immune escape of tumor cells and less benefit from immune checkpoint blockade (ICB) treatment. The mechanisms underlying immunotherapeutic resistance in MSS CRC remain to be elucidated. Here, we identified that nuclear proto‐oncogene SET is significantly higher expressed in MSS CRC compared to microsatellite instability (MSI) CRC and facilitates immune escape of MSS CRC. Mechanistically, SET represses the expression of C‐C motif chemokine ligand 5 (CCL5) and upregulates mismatch repair (MMR) proteins expression in a c‐Myc‐dependent manner, which inhibits infiltration and migration of CD8 + T cells to tumor tissues and results in low immunogenicity in MSS CRC. In addition, we found that SET impairs ubiquitination and proteasomal degradation of c‐Myc by disrupting the interaction between E3 ligase FBXW7 and c‐Myc. Moreover, SET inhibition enhances the response to immunotherapy in MSS CRC in vivo. Overall, this study reveals the critical roles and posttranslational regulatory mechanism of SET in immune escape and highlights the SET/c‐Myc axis as a potential target for immunotherapy of MSS CRC that have implications for targeting a unique aspect of this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
- Department of Oncology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.
- Hubei Clinical Center and Key Lab of Intestinal and Colorectal Diseases, Wuhan, Hubei, China.
Förderung
- National Natural Science Foundation of China
- The Young Top-notch Talent Cultivation Program of Hubei Province
- Zhongnan Hospital of Wuhan University
- Hubei Provincial Natural Science Foundation of China
Zitieren
APA
Gao, L., Li, Y., Wang, H., Liu, J., Zhang, R., Shan, W., Zeng, L., Zhao, Q., Li, Y., & Liu, J. (2025). SET facilitates immune escape of microsatellite stability colorectal cancer by inhibiting c‐Myc degradation. Cancer Science. https://doi.org/10.1111/cas.16368
Vancouver
Gao L, Li Y, Wang H, Liu J, Zhang R, Shan W, et al. SET facilitates immune escape of microsatellite stability colorectal cancer by inhibiting c‐Myc degradation. Cancer Science. 2025. doi:10.1111/cas.16368
BibTeX
@article{Gao2025,
author = {Gao, Liping and Li, Yizhang and Wang, Haizhou and Liu, Jialong and Zhang, Ranran and Shan, Wenqing and Zeng, Lingxiu and Zhao, Qiu and Li, Yong and Liu, Jing},
title = {SET facilitates immune escape of microsatellite stability colorectal cancer by inhibiting c‐Myc degradation},
journal = {Cancer Science},
year = {2025},
doi = {10.1111/cas.16368}
}
EUVIMED